Mohit Agarwal

Mohit Agarwal practices at Banner Alzheimer's Institute in Sun City, Arizona.

Mohit Agarwal's NPI, 1407061781, was assigned on May 11, 2007. Mohit Agarwal holds Arizona license 56337.

Mohit Agarwal's primary practice is Banner Alzheimer's Institute, at 10515 W Santa Fe Dr, Sun City, AZ 85351 in Maricopa County. The practice phone is (602) 747-4000.

Mohit Agarwal's primary practice is Banner Alzheimer's Institute in Sun City, Arizona. Mohit Agarwal is also affiliated with Froedtert Hospital. The medical group on file is Banner Medical Group (BMG). Dmand AI also links Mohit Agarwal to 3 more hospitals, 3 medical groups, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mohit Agarwal practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Mohit Agarwal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Mohit Agarwal's licenses on file in 5 states: Arizona, Michigan, Mississippi, Ohio and Wisconsin.

CMS data shows 2,857 Medicare services from Mohit Agarwal across 22 procedure codes in 2024, for 476 Medicare patients. Medicare paid $156,809 for them.

CMS counts 476 Medicare patients who saw Mohit Agarwal in 2024. The largest group is 75 to 84, with 178 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mohit Agarwal's median patient age at 64, with 45% women.

In 2024, Mohit Agarwal wrote 2,209 Medicare Part D claims for 388 patients. 75% of them were for generic drugs. CMS names the drug for 2,026 of them, across 38 drugs with 11 or more claims each, at $410,453 in total drug cost. In 2023, CMS named 1,645 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Mohit Agarwal for performance year 2024, reported individually. Mohit Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Mohit Agarwal, published from 2016 to 2017. 2016 was the busiest year, with 2. The most frequent topics are Renal Dialysis and Renal Insufficiency, Chronic. Mohit Agarwal has published most often in Am J Med Sci. Mohit Agarwal's most frequent co-authors are Luis A. Juncos, MD, Joseph Michael Brewer, DO and Vishnu Vardhan Garla, MD.

CMS Open Payments shows 255 general payments to Mohit Agarwal from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $579.